Transforming Outpatient Surgery with DEXTER
In a remarkable development, Distalmotion, a pioneering MedTech company, is making waves in the healthcare landscape with the introduction of its DEXTER® Robotic Surgery System. This innovative system is designed to broaden access to robotic surgery, particularly in outpatient settings, where efficiency and flexibility are paramount. The recent acquisition by AdventHealth represents a significant step towards that goal, marking the first multi-robot sale of DEXTER in the United States.
The AdventHealth Acquisition
AdventHealth, a massive healthcare provider operating 50 hospitals across nine states, has recognized the potential of the DEXTER system in transforming its surgical offerings. This initiative aims to enhance minimally invasive surgical procedures in its outpatient department. Dr. Carlos Ortiz-Ortiz, a general surgeon at AdventHealth, expresses enthusiasm for the partnership, emphasizing how DEXTER meets their commitment to adaptable and efficient surgical solutions.
Why DEXTER Stands Out
The DEXTER Robotic Surgery System comes with unique features that distinguish it from traditional surgical robots. Its compact and mobile design allows for easy maneuverability between operating rooms, which can significantly reduce turnaround times for procedures. This capability is essential as more surgical operations transition to outpatient care settings. Furthermore, DEXTER's sterile console facilitates seamless workflows, allowing surgeons to switch rapidly between bedside tasks and robotic operations without losing sterility.
Addressing the Challenges in Surgical Robotics
As surgery centers face increasing demands for efficiency and better patient experiences, DEXTER offers healthcare facilities a practical and versatile solution. Traditional surgical robots often pose challenges due to their size, complexity, and costs, which can be barriers for many facilities. In contrast, DEXTER is designed to integrate effortlessly into any operating room, minimizing operational disruptions and maximizing value.
Healthcare System Insights
The growing interest in robotic surgery speaks to a broader trend in healthcare where facilities are increasingly leaning towards more adaptable technologies. Greg Roche, the CEO of Distalmotion, emphasizes that the recent acquisition underscores the need for flexible solutions that can enhance surgical capabilities across various care settings. Such advancements not only benefit healthcare systems but also aim to improve outcomes for patients undergoing surgery.
Global Impact of DEXTER
Distalmotion's DEXTER system is gaining traction globally, building on a growing footprint in both the US and European markets. To date, more than 2,000 procedures have been performed using DEXTER in various specialties, including general, gynecological, and urological surgery. The company's mission remains focused on making robotic surgery accessible to a broader range of facilities and surgeons worldwide, expanding the reach of high-quality care.
Innovative Features of DEXTER
DEXTER is not just another robotic surgery system; it is designed with features that significantly enhance surgical outcomes. The system includes fully wristed single-use robotic instruments that provide surgeons with improved dexterity and precision. Furthermore, its open architecture enables compatibility with a wide array of existing operating room technologies, thus ensuring that healthcare providers can continue using the equipment they already have.
Regulatory Framework
In the United States, the DEXTER Robotic Surgery System has been authorized for laparoscopic adult inguinal hernia repair and cholecystectomy. This regulatory milestone reinforces its intended use and value in improving surgical procedures. In Europe, DEXTER serves multiple laparoscopic surgical procedures, further solidifying its global acceptance.
About Distalmotion
Headquartered in Lausanne, Switzerland, Distalmotion is dedicated to advancing medical technology by simplifying the operations of robotic surgery. By making DEXTER available in both the United States and Europe, the company is intensifying efforts to broaden access to robotic surgical solutions for a diverse range of healthcare facilities, including outpatient departments and surgical centers. Their innovative approach continues to pave the way for effective integration of robotic systems in modern surgical practices.
Frequently Asked Questions
What is the DEXTER Robotic Surgery System?
The DEXTER Robotic Surgery System is a compact robotic surgery platform designed to enhance surgical precision and efficiency in various minimally invasive procedures.
Who acquired the DEXTER surgical systems?
AdventHealth acquired multiple DEXTER Robotic Surgery Systems to enhance its outpatient surgery capabilities.
What are the main applications of DEXTER in surgery?
DEXTER is currently indicated for laparoscopic inguinal hernia repair and cholecystectomy in the US, as well as various laparoscopic procedures in Europe.
How does DEXTER improve surgical efficiency?
Its small, mobile design allows for quick setup and seamless transitions between robotic and laparoscopic techniques, optimizing operating room turnover times.
Where is Distalmotion headquartered?
Distalmotion is headquartered in Lausanne, Switzerland, with a US office located in Cleveland, Ohio.
